Page last updated: 2024-09-04

fidarestat and azoxymethane

fidarestat has been researched along with azoxymethane in 1 studies

Compound Research Comparison

Studies (fidarestat)	Trials (fidarestat)	Recent Studies (post-2010) (fidarestat)	Studies (azoxymethane)	Trials (azoxymethane)	Recent Studies (post-2010) (azoxymethane)
97	3	33	1,766	1	745

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ramana, KV; Saxena, A; Shoeb, M; Srivastava, SK; Tammali, R	1

Other Studies

1 other study(ies) available for fidarestat and azoxymethane

Article	Year
Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Cancer letters, 2014, Dec-01, Volume: 355, Issue:1 Topics: Aldehyde Reductase; Animals; Anticarcinogenic Agents; Azoxymethane; Colon; Colonic Neoplasms; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; HT29 Cells; Humans; Imidazolidines; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress; Precancerous Conditions; Signal Transduction	2014

Article

Year

Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.

Cancer letters, 2014, Dec-01, Volume: 355, Issue:1

Topics: Aldehyde Reductase; Animals; Anticarcinogenic Agents; Azoxymethane; Colon; Colonic Neoplasms; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; HT29 Cells; Humans; Imidazolidines; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress; Precancerous Conditions; Signal Transduction

2014